Results 41 to 50 of about 4,100,045 (206)
Gut microbiota and cardiac arrhythmia: a pharmacokinetic scope
Background Dealing with cardiac arrhythmia is a difficult challenge. Choosing between different anti-arrhythmic drugs (AADs) while being cautious about the pro-arrhythmic characteristics of some of these drugs and their diverse interaction with other ...
Omnia Azmy Nabeh
core +1 more source
Sepsis-associated atrial fibrillation (SAAF) is a common but serious complication in critically ill patients that is characterized by new-onset atrial fibrillation (AF) during sepsis.
Alison C. Leslie +2 more
doaj +1 more source
Heat shock proteins (HSPs) are endogenous protective proteins and biomarkers of cell stress response, of which examples are HSP70, HSP60, HSP90, and small HSPs (HSPB).
Daiqi Liu +5 more
doaj +1 more source
Background: Thiadiazole has attracted a great deal of interest as a versatile heterocycle for the discovery and development of potent anticancer agents. Thiadiazole derivatives exert potent antitumor activity against a variety of human cancer cell lines ...
Turan, Gulhan +16 more
core +1 more source
Introduction. Cardiac arrhythmias represent a diagnostic and therapeutic challenge in emergency departments. Objective. To describe the diagnostic accuracy and management practices of cardiac arrhythmias in the emergency department of a tertiary ...
Alejandro Ceballos-Rivera +7 more
doaj +1 more source
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited, stressed-provoked ventricular arrhythmia. CPVT is treated by β-adrenergic receptor blockers, Na+ channel inhibitors, sympathetic denervation, or by implanting a defibrillator ...
Hanna Bueno-Levy +8 more
doaj +1 more source
Sodium-glucose transporter 2 inhibitors have been identified as pleiotropic pharmacological agents with demonstrated efficacy in a wide range of pathologies.
Prația-Aron Diana-Ioana +2 more
doaj +1 more source
Symptomatic Myocardial Bridging Treated by Coronary Stenting
Background : Myocardial bridging is a congenital coronary anomaly with mostly benign course throughout life. However, several pathological clinical manifestations may accompany myocardial bridging, such as arrhythmia, angina, depressed left ventricular ...
Johan Winata +3 more
doaj +1 more source
BackgroundCombined treatment with anthracyclines (e.g., doxorubicin; Dox) and trastuzumab (Trz), a humanized anti-human epidermal growth factor receptor 2 (HER2; ErbB2) antibody, in patients with HER2-positive cancer is limited by cardiotoxicity, as ...
Claudia Altomare +19 more
doaj +1 more source
Role of Pulmonary Vein in Atrial Fibrillation
Background. Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, occurring in1–2% of the general population and likely to increase in next 50 years.
Dian Andina Munawar, Yoga Yuniadi
doaj +1 more source

